Operational tolerance in clinical liver transplantation: emerging developments. (Q48413245)

11 February 2018

editorial

0 references

title

Operational tolerance in clinical liver transplantation: emerging developments. (English)

1 reference

11 February 2018

main subject

liver transplantation

1 reference

Mario Angelico

3

0 references

author name string

Giuseppe Tisone

series ordinal

1

1 reference

11 February 2018

Giuseppe Orlando

series ordinal

2

1 reference

11 February 2018

publication date

27 September 2006

1 reference

11 February 2018

published in

Transplant Immunology

1 reference

11 February 2018

volume

17

1 reference

11 February 2018

page(s)

108-113

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

The mystique of organ transplantation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Immunosuppressive drugs and the risk of cancer after organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Increased cancer risk after liver transplantation: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Beyond operational tolerance: effect of ischemic injury on development of chronic damage in renal grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Is clinical tolerance realistic in the next decade?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Prope tolerance: the future of organ transplantation--from the laboratory to the clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

The concept of "partial" clinical tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Cost and outcome analysis and cost determinants of liver transplantation in a European National Health Service hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Long-term effects of transplantation on quality of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Immunological tolerance and liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Weaning of immunosuppression in liver transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Weaning of immunosuppression in long-term liver transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Defining the outcome of immunosuppression withdrawal after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Long-term outcome of immunosuppression withdrawal after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Analysis of alloreactivity and intragraft cytokine profiles in living donor liver transplant recipients with graft acceptance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Weaning of immunosuppression in living donor liver transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Analyses of Peripheral Blood Mononuclear Cells in Operational Tolerance After Pediatric Living Donor Liver Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Tolerogenic immunosuppression for organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Lessons of organ-induced tolerance learned from historical clinical experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Tolerance: is it worth the risk?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Toward tolerance to human organ transplants: a few additional corollaries and questions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Metastable tolerance in nonhuman primates and humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Approaches to transplantation tolerance in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

The immunological monitoring of alloreactive responses in liver transplant recipients: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

What determines the natural history of recurrent hepatitis C after liver transplantation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Liver Transplantation and Hepatitis C. Proceedings of a consensus development symposium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Corticosteroids enhance hepatic injury following ischemia-reperfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Preclinical Evaluation of Two Neutralizing Human Monoclonal Antibodies against Hepatitis C Virus (HCV): a Potential Treatment To Prevent HCV Reinfection in Liver Transplant Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Pegylated interferon alpha-2b for patients with HCV recurrence and graft fibrosis following liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Liver transplantation and hepatitis C virus: systematic review of antiviral therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Treatment of hepatitis B and C after liver transplantation. Part 2, hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Coffee, cirrhosis, and transaminase enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Ethics in the quest for transplant tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Human allograft acceptance is associated with immune regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

Basic concepts in transplant immunology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2006.09.021

10.1016/J.TRIM.2006.09.021

7 January 2021

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

17306741

1 reference

11 February 2018